APAC Enteral Feeding Devices Market

APAC Enteral Feeding Devices Market Size (2023 to 2028)

The size of the Asia Pacific enteral feeding devices market is estimated to be growing at a CAGR of 5.35% from 2023 to 2028 and be worth USD 0.61 billion in 2023 and USD 0.79 billion by 2028.

The growing incidence of pre-term births across the APAC region, the growing geriatric population, and rising awareness around enteral nutrition drive the Asia Pacific market growth. For example, according to data published by WHO, an estimated 3.5 million pre-term births were registered in India from January 2014 to November 2015. In addition, factors such as the growing demand for enteral feeding devices from the home healthcare sector and the increasing prevalence of chronic diseases are expected to fuel the growth rate of the enteral feeding devices market in the APAC region. The growing number of patients suffering from malnutrition is one of the notable factors that propel the regional market growth. In addition, the rising geriatric population suffering from neurological conditions such as multiple sclerosis, stroke, and dementia that impact swallowing is the most significant target population. Thus, nutritional support in oral nutrition supplements and enteral feeding tube support mitigates the challenges of nutrition deficits among these diagnosed people. Furthermore, the high prevalence of premature births, especially in developing economies such as China and India, is among the key factors driving the enteral feeding devices market. Furthermore, APAC's enteral feeding devices market is driven by technological advancements that improve dense, small, lightweight enteral feeding pumps manufactured using durable materials.

However, the unavailability of reimbursement policies in some parts of the Asia-Pacific region is one of the major factors hampering the enteral feeding devices market in this region. In addition, the lack of R&D activities toward enteral feeding therapy and devices is expected to impact the market's growth rate in this region negatively.

This research report on the APAC Enteral Feeding Devices Market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Enteral Feeding Tubes
  • Nasoenteric Feeding Tubes
  • Oroenteric Feeding Tubes
  • Enterostomy Tubes
• Giving Sets
• Enteral Feeding Pumps
• Administration Reservoirs
• Enteral Syringes
• Others

Based on product type, the enteral feeding pump segment occupied the major share of the APAC market in 2021.

By Stage: 

• Adults
• Pediatrics

By Application: 

• Gastroenterology
• Neurological Disorders
• Oncology
• Diabetes
• Hyper Metabolism

By End User: 

• Ambulatory Care Services
• Hospitals
• Others

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Regionally, the Asia-Pacific enteral feeding devices market is expected to record the highest CAGR among all the regions during the forecast period. China is the largest market for enteral feeding devices in this region in 2021 and is expected to hold the most significant share of the APAC market during the forecast period. In addition, India is also a potential target for enteral feeding device manufacturers due to its high propensity for chronic diseases such as diabetes and cancer. The growing number of hospitals and increasing efforts by the governments to improve the healthcare infrastructure among the Asia Pacific countries are estimated to favor the market growth in India. The rapidly growing geriatric population and increasing nutritional deficiency problems among people support the market's growth rate in India. About 190.7 million people suffer from malnutrition in India. More than 53% of deaths occur due to chronic disease, suggesting a rise in enteral feeding therapy and devices across homecare services and hospitals.

KEY MARKET PLAYERS:

A few of the leading players in the APAC enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.